Search For "drug regulator"
Drug Regulatory of Pakistan approves Paracetamol price hike
Updated : 4 years, 3 months ago IST
Islamabad [Pakistan], February 3 (ANI): The price of Paracetamol, the most commonly prescribed medicine for COVID patients, has now been increased, with the Drug Regulatory of Pakistan (DRAP) approving the hike and fixing the rate up to Rs 2.67 per tablet.
Read More
Paracetamol disappears from Pakistan's pharmacies as Dengue cases rise
Updated : 4 years, 3 months ago IST
Islamabad [Pakistan], February 2 (ANI): Paracetamol is unavailable in many of Pakistan's pharmacies and is reportedly being sold in the black market, reported DAWN.
Read More
SEC recommends emergency use authorization of Covovax, Corbevax vaccines f
Updated : 4 years, 5 months ago IST
New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
Read More
SEC to take decision on antiviral Covid pill today
Updated : 4 years, 5 months ago IST
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject expert committee (SEC) a body under India's drug regulator will be meeting today for antiviral pill Molnupiravir recommendations, sources told to ANI.
Read More
SII seeks approval for Covishield vaccine as booster dose amid Omicron var
Updated : 4 years, 5 months ago IST
New Delhi [India], December 2 (ANI): The Serum Institute of India (SII) has sought India's drug regulator's approval for the Covishield vaccine as a booster dose citing adequate stock of the vaccine in the country, officials informed ANI on Thursday.
Read More
EU drug regulator to add brain blood clot warning to AstraZeneca vaccine
Updated : 4 years, 6 months ago IST
Brussels [Belgium], November 11 (ANI/Sputnik): The EU drug regulator advised on Thursday listing blood clots in the brain as a rare side effect of AstraZeneca's COVID-19 after observing cases that were not linked to a low platelet count.
Read More
Biological E gets drug regulator's approval to conduct phase 2/3 trials on
Updated : 4 years, 8 months ago IST
New Delhi [India], September 2 (ANI): The Drug Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 & 3 clinical trials for its anti-COVID shots called Corbevax on children between 5 and 18 years of age with certain
Read More
Will take another 4-5 months to publish phase 3 trials data of ZyCoV-D vac
Updated : 4 years, 9 months ago IST
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the p
Read More
US approves third dose of COVID vaccine for people with weak immune system
Updated : 4 years, 9 months ago IST
Washington [US] August 13 (ANI/FENA): US drug regulators say transplant recipients and others with severely weakened immune systems may receive an extra dose of Pfizer or Moderna to better protect them as the delta variant of the coronavirus continues to spread.
Read More
Zydus Cadila submits additional data to DCGI for its COVID-19 vaccine: Sou
Updated : 4 years, 10 months ago IST
New Delhi [India], July 27 (ANI): Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D, to India's drug regulator Drugs Controller General of India (DCGI), sources said on Tuesday.
Read More
Granules India subsidiary clears USFDA audit
Updated : 4 years, 10 months ago IST
Hyderabad (Telangana) [India], July 21 (ANI): The drug maker Granules India on Wednesday announced that its US-based subsidiary cleared a pre-approval inspection (PAI) audit by the US drug regulator.
Read More
Emergency approval for Zydus Cadila to take few more days, say sources
Updated : 4 years, 10 months ago IST
New Delhi [India], July 12 (ANI): India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its COVID-19 vaccine ZyCoV-D in a few more days, sources told ANI.
Read More